 |
 |

The Use of Dextroamphetamine to Treat Obesity and Hyperphagia in Children Treated for Craniopharyngioma
Patrick W. Mason, MD, PhD;
Nicolas Krawiecki, MD;
Lillian R. Meacham, MD
Arch Pediatr Adolesc Med. 2002;156:887-892.
Background Obesity and attention difficulties are known complications following
surgical treatment for craniopharyngioma. Treatments to date have been largely
disappointing.
Objective To examine the use of the central nervous system stimulant dextroamphetamine
sulfate to regulate appetite and subsequent weight gain in children treated
for craniopharyngioma.
Setting A multidisciplinary clinic specializing in pediatric brain tumors.
Patients Five consecutive patients with significant weight gain and poor attention
following surgical treatment for craniopharyngioma were selected for the study.
Intervention Children enrolled in the study were treated with dextroamphetamine,
and growth, laboratory, and behavioral assessments were conducted for 24 months.
Results Mean ± SD body mass index (weight in kilograms divided by height
in meters squared) increased from 21 ± 3.5 before the operation to
32 ± 2.8 by the start of the protocol. Body mass indices remained stable
throughout the protocol. No changes were observed in insulin levels or caloric
intake, but the children were more active when taking dextroamphetamine. Parents
noted a significant improvement in hyperactivity (mean ± SD, 1.2 ±
0.4 to 0.6 ± 0.2; P = .05), scored with the
Conners Parent and Teacher Rating Scales. Teachers noted a similar improvement.
Conclusions During dextroamphetamine treatment, weight gain stabilized in children
who had experienced obesity following surgical resection for craniopharyngioma.
In addition, parents and teachers noted significant improvements in children's
overall activity and attention. Further studies are needed to determine if
the improvements are stable and if earlier intervention can prevent the initial
obesity.
From the Inova Fairfax Hospital for Children, Fairfax, Va (Dr Mason);
and the Divisions of Pediatric Neurology (Dr Krawiecki) and Pediatric Endocrinology
(Dr Meacham), Emory University, Atlanta, Ga.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Distal gastric bypass surgery for the treatment of hypothalamic obesity after childhood craniopharyngioma
Schultes et al.
Eur J Endocrinol 2009;161:201-206.
ABSTRACT
| FULL TEXT
Reductions in Basal Metabolic Rate and Physical Activity Contribute to Hypothalamic Obesity
Shaikh et al.
J. Clin. Endocrinol. Metab. 2008;93:2588-2593.
ABSTRACT
| FULL TEXT
Obesity in Patients with Craniopharyngioma: Assessment of Food Intake and Movement Counts Indicating Physical Activity
Harz et al.
J. Clin. Endocrinol. Metab. 2003;88:5227-5231.
ABSTRACT
| FULL TEXT
Octreotide Therapy of Pediatric Hypothalamic Obesity: A Double-Blind, Placebo-Controlled Trial
Lustig et al.
J. Clin. Endocrinol. Metab. 2003;88:2586-2592.
ABSTRACT
| FULL TEXT
|